---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-008750"
form_type: "8-K"
ticker: "MAIA"
cik: "0001878313"
company_name: "MAIA Biotechnology, Inc."
filed_at: "2025-05-06T23:59:59+00:00"
generated_at: "2026-05-22T14:12:19.533441+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# MAIA raises $1.08M in private placement; warrants corrected to 1-year lockout, 6-year term

## Summary
- 719,999 shares sold at $1.50/share; each with a warrant to buy one share at $2.05.
- Warrants exercisable starting 1 year from issuance, expiring 6 years from issuance date.
- Directors Stan Smith ($100K) and Ramiro Guerrero ($30K) participated in the offering.
- Net proceeds to fund Part C of THIO-101 Phase II trial and working capital.
- Closing expected on or about May 7, 2025, subject to customary conditions.

## SEC filing metadata
- accession: 0001641172-25-008750
- form_type: 8-K
- ticker: MAIA
- cik: 0001878313
- company_name: MAIA Biotechnology, Inc.
- filed_at: 2025-05-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1878313/000164117225008750/0001641172-25-008750-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1878313/000164117225008750/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-008750
- JSON: https://secwatch.observer/filing/0001641172-25-008750.json
- Plain text: https://secwatch.observer/filing/0001641172-25-008750.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.